Dicerna Pharmaceuticals, Inc. Gains 78.71%
Thu, Nov 18, 2021 at 05:30 PM
Dicerna Pharmaceuticals, Inc. (DRNA:NASDAQ) rocketted at $38.03, representing a gain of 78.7%. On Wed, Nov 17, 2021, DRNA:NASDAQ hit a New 2-Week Intraday Low of $21.18. The stock appeared on our News Catalysts scanner on Thu, Nov 18, 2021 at 05:23 PM in the 'INVESTOR UPDATE' category. From Wed, Nov 03, 2021, the stock recorded 60.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Dicerna Pharmaceuticals, Inc. (DRNA:NASDAQ)
Dicerna Pharmaceuticals Inc is a biopharmaceutical company. It develops ribonucleic acid interference-based pharmaceuticals for treating diseases involving liver, including rare, chronic liver, cardiovascular and viral infections.
Top 10 Gainers:
- LGVN (LGVN:NASDAQ), 135.27%
- Dicerna Pharmaceuticals, Inc. (DRNA:NASDAQ), 78.71%
- Sirius International Insurance Group, Ltd. (SG:NASDAQ), 76.79%
- VOSO (VOSO:NASDAQ), 43.95%
- ClearSign Technologies Corporation (CLIR:NASDAQ), 36.09%
- JWEL (JWEL:NASDAQ), 25.75%
- Macy's, Inc. (M:NYSE), 21.17%
- BJ's Wholesale Club Holdings, Inc. (BJ:NYSE), 19.94%
- CRDF (CRDF:NASDAQ), 18.74%
- Arcus Biosciences, Inc. (RCUS:NYSE), 17.96%